(Reuters) – AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their respective rheumatoid
AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs

besthealthtale.com
Home ยป
(Reuters) – AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their respective rheumatoid